SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-23-001332
Filing Date
2023-12-21
Accepted
2023-12-21 14:30:33
Documents
13
Period of Report
2023-12-21
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K novaccess20231221_8k.htm   iXBRL 8-K 22333
  Complete submission text file 0001185185-23-001332.txt   158391

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xsnx-20231221.xsd EX-101.SCH 3217
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xsnx-20231221_def.xml EX-101.DEF 10587
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xsnx-20231221_lab.xml EX-101.LAB 19935
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xsnx-20231221_pre.xml EX-101.PRE 10961
7 EXTRACTED XBRL INSTANCE DOCUMENT novaccess20231221_8k_htm.xml XML 2465
Mailing Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023
Business Address 8584 E. WASHINGTON STREET, NO. 127 CHAGRIN FALLS OH 44023 (213) 642-9268
NovAccess Global Inc. (Filer) CIK: 0001039466 (see all company filings)

IRS No.: 841384159 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-29621 | Film No.: 231504647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)